Mid Atlantic Retina, Wills Eye Hospital — Philadelphia, Pennsylvania

Mid Atlantic Retina, Wills Eye Hospital is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid Atlantic Retina, Wills Eye Hospital has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Geographic Atrophy.

Sponsors: Regeneron Pharmaceuticals, Apellis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Atlantic Retina, Wills Eye Hospital?

Mid Atlantic Retina, Wills Eye Hospital has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Atlantic Retina, Wills Eye Hospital conducted?

Mid Atlantic Retina, Wills Eye Hospital has 2 clinical trials on record, with 1 currently active. Their work covers Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Geographic Atrophy.

Is Mid Atlantic Retina, Wills Eye Hospital accredited by Crixeo Health?

Mid Atlantic Retina, Wills Eye Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Atlantic Retina, Wills Eye Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.